Two studies have investigated the prognostic significance of tumour VEGF levels in anal cancer patients treated with chemoradiotherapy, but neither study identified a correlation with patient survival (Table 7) (Wong et al, 1999; Ajani et al, 2009). The gene discussed is VEGFA; the disease is neoplasm.